Polysorbate-80-coated, polymeric curcumin nanoparticles for in vivo anti-depressant activity across BBB and envisaged biomolecular mechanism of action through a proposed pharmacophore model

References

• Ahmed T, Enam SA, Gilani AH. Curcuminoids enhance memory in an amyloid-infused rat model of Alzheimer's disease. Neuroscience, 2010;169:1296–306.
   PubMed Web of Science ®Google Scholar
• Ak T, Gülçin İ. Antioxidant and radical scavenging properties of curcumin. Chem–Biol Interact, 2008;174:27–37.
   PubMed Web of Science ®Google Scholar
• Al-Rubaei ZM, Mohammad TU, Ali LK. Effects of local curcumin on oxidative stress and total antioxidant capacity in vivo study. Pak J Biol Sci, 2014;17:1237–41.
   PubMedGoogle Scholar
• Aluf Y, Vaya J, Khatib S, Loboda Y, Finberg JP. Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway. Neuropharmacology, 2013;65:48–57.
   PubMed Web of Science ®Google Scholar
• Anand P, Kunnumakkara A, Newman R, Aggarwal B. Bioavailability of curcumin: Problems and promises. Mol Pharm, 2007;4:807–18.
   PubMed Web of Science ®Google Scholar
• Azadi A, Hamidi M, Khoshayand MR, Amini M, Rouini MR. Preparation and optimisation of surface-treated methotrexate-loaded nanogels intended for brain delivery. Carbohydrate Polymers, 2012;90:462–71.
   PubMed Web of Science ®Google Scholar
• Badavath VN, Baysal İ, Ucar G, Sinha BN, Jayaprakash V. Monoamine oxidase inhibitory activity of novel pyrazoline analogues: Curcumin based design and synthesis. ACS Med Chem Lett, 2016;7:56–61.
   PubMed Web of Science ®Google Scholar
• Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov, 2004;3:205–14.
   PubMed Web of Science ®Google Scholar
• Belviranli M, Okudan N, Atalik KE, Oz M. Curcumin improves spatial memory and decreases oxidative damage in aged female rats. Biogerontology, 2013;14:187–96.
   PubMed Web of Science ®Google Scholar
• Bhutani MK, Bishnoi M, Kulkarni S. Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioural, biochemical and neurochemical changes. Pharmacol Biochem Behav, 2009;92:39–43.
   PubMed Web of Science ®Google Scholar
• Chavanpatil MD, Patil Y, Panyam J. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux. Int J Pharm, 2006;320:150–6.
   PubMed Web of Science ®Google Scholar
• Choi SI, Kim TI, Kim KS, Kim BY, Ahn SY, Cho HJ, Lee HK, Cho HS, Kim EK. Decreased catalase expression and increased susceptibility to oxidative stress in primary cultured corneal fibroblasts from patients with granular corneal dystrophy type II. Am J Pathol, 2009;175:248–61.
   PubMed Web of Science ®Google Scholar
• Dar A, Khatoon S. Behavioural and biochemical studies of dichloromethane fraction from the areca catechu nut. Pharmacol Biochem Behav, 2000;65:1–6.
   PubMed Web of Science ®Google Scholar
• Das MK, Husain K, Pathak Y. Brain targeted delivery of curcumin using P80-PEG-coated poly (lactide-co-glycolide) nanoparticles. Asian J Chem, 2013;25:S297.
   Google Scholar
• Desgouilles SP, Vauthier C, Bazile D, Vacus JL, Grossiord JL, Veillard M, Couvreur P. The Design of nanoparticles obtained by solvent evaporation: A comprehensive study. Langmuir, 2003;19:9504–10.
   Web of Science ®Google Scholar
• Faisant N, Siepmann J, Benoit JP. PLGA-based microparticles: Elucidation of mechanisms and a new, simple mathematical model quantifying drug release. Eur J Pharm Sci, 2002;15:355–66.
   PubMed Web of Science ®Google Scholar
• Federici E, Multari G, Gallo FR, Palazzino G. Herbal drugs: From traditional use to regulation. Ann Ist Super Sanita, 2005;41:49–54.
   PubMedGoogle Scholar
• Feng SS, Huang G. Effects of emulsifiers on the controlled release of paclitaxel (Taxol®) from nanospheres of biodegradable polymers. J Control Release, 2001;71:53–69.
   PubMed Web of Science ®Google Scholar
• Firenzuoli F, Gori L. Herbal Medicine Today: Clinical and Research Issues. Evidence-based Complem Alternat Med, 2007;4:37–40.
   PubMed Web of Science ®Google Scholar
• Frey BCN, Andreazza AC, Kunz MC, Gomes FA, Quevedo JO, Salvador M, Gonã§Alves CA, Kapczinski FV. Increased oxidative stress and DNA damage in bipolar disorder: A twin-case report. Progr Neuro-Psychopharmacol Biol Psychiatry, 2007;31:283–5.
   PubMed Web of Science ®Google Scholar
• Gandhi S, Abramov A. Mechanism of oxidative stress in neurodegeneration. Oxidative Med Cell Longevity, 2012;2012:428010.
   PubMed Web of Science ®Google Scholar
• Girgin Sagin F, Sozmen EY, Ersoz B, Mentes G. Link between monoamine oxidase and nitric oxide. NeuroToxicol, 2004;25:91–9.
   PubMed Web of Science ®Google Scholar
• Grabovac V, Bernkop-Schnirch A. Development and in vitro evaluation of surface modified poly(lactide-co-glycolide) nanoparticles with chitosan-4-thiobutylamidine. Drug Dev Industrial Pharm, 2007;33:767–74.
   PubMed Web of Science ®Google Scholar
• Gulyaev AE, Gelperina SE, Skidan IN, Antropov AS, Kivman GY, Kreuter J. Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles. Pharm Res, 1999;16:1564–9.
   PubMed Web of Science ®Google Scholar
• Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J, 2013;15:195–218.
   PubMed Web of Science ®Google Scholar
• Halliwell B. 1998. Free radicals and oxidative damage in biology and medicine: An introduction. In Reznick AZ, Packer L, Sen CK, Holloszy JO, Jackson MJ, editors. Oxidative stress in skeletal muscle. Basel: Birkhäuser Basel, pp. 1–27.
   Google Scholar
• Hassan W, Noreen H, Castro-Gomes V, Mohammadzai I, Da Rocha JB, Landeira-Fernandez J. Association of oxidative stress with psychiatric disorders. Curr Pharm Des, 2016;22:2960–74.
   PubMed Web of Science ®Google Scholar
• Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci, 1963;52:1145–9.
   PubMed Web of Science ®Google Scholar
• Imlay JA. The molecular mechanisms and physiological consequences of oxidative stress: lessons from a model bacterium. Nat Rev Micro, 2013;11:443–54.
   PubMed Web of Science ®Google Scholar
• Karolewicz B, Paul IA. Group housing of mice increases immobility and antidepressant sensitivity in the forced swim and tail suspension tests. Eur J Pharmacol, 2001;415:197–201.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA, 2003;289:3095–105.
   PubMed Web of Science ®Google Scholar
• Kirsch I. Antidepressants and the placebo effect. Zeitschr Psychol, 2014;222:128–34.
   Google Scholar
• Kreuter J, Alyautdin RN, Kharkevich DA, Ivanov AA. Passage of peptides through the blood–brain barrier with colloidal polymer particles (nanoparticles). Brain Res, 1995;674:171–4.
   PubMed Web of Science ®Google Scholar
• Kreuter J, Ramge P, Petrov V, Hamm S, Gelperina SE, Engelhardt B, Alyautdin R, Von Briesen H, Begley DJ. Direct evidence that polysorbate-80-coated poly (butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles. Pharma Res, 2003;20:409–16.
   Web of Science ®Google Scholar
• Kreuter J, Shamenkov D, Petrov V, Ramge P, Cychutek K, Koch-Brandt C, Alyautdin R. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood–brain barrier. J Drug Target, 2002;10:317–25.
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Bhutani M, Bishnoi M. Antidepressant activity of curcumin: Involvement of serotonin and dopamine system. Psychopharmacology, 2008;201:435–42.
   PubMed Web of Science ®Google Scholar
• Lao LL, Venkatraman SS, Peppas NA. Modelling of drug release from biodegradable polymer blends. Eur J Pharm Biopharm, 2008;70:796–803.
   PubMed Web of Science ®Google Scholar
• Lü JM, Wang X, Marin-Muller C, Wang H, Lin PH, Yao Q, Chen C. Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagnostics, 2009;9:325–41.
   PubMed Web of Science ®Google Scholar
• Mahakunakorn P, Tohda M, Murakami Y, Matsumoto K, Watanabe H, Vajaragupta O. Cytoprotective and cytotoxic effects of curcumin: Dual action on H2O2-induced oxidative cell damage in NG108-15 cells. Biol Pharm Bull, 2003;26:725–8.
   PubMed Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel), 2011;3:1377–97.
   PubMed Web of Science ®Google Scholar
• Manaenko A, Chen H, Kammer J, Zhang JH, Tang J. Comparison Evans Blue injection routes: Intravenous versus intraperitoneal, for measurement of blood–brain barrier in a mice haemorrhage model. J Neurosci Methods, 2011;195:206–10.
   PubMed Web of Science ®Google Scholar
• Mathew A, Fukuda T, Nagaoka Y, Hasumura T, Morimoto H, Yoshida Y, Maekawa T, Venugopal K, Kumar DS. Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer's disease. PLoS One, 2012;7:e32616.
   PubMed Web of Science ®Google Scholar
• Mehlum L, Ramberg M, Tørmoen AJ, Haga E, Diep LM, Stanley BH, Miller AL, Sund AM, Grøholt B. Dialectical behaviour therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behaviour: Outcomes over a one-year follow-up. J Am Acad Child Adolesc Psychiatry, 2016;55:295–300.
   PubMed Web of Science ®Google Scholar
• Menniti-Ippolito F, Mazzanti G, Vitalone A, Firenzuoli F, Santuccio C. Surveillance of suspected adverse reactions to natural health products: the case of propolis. Drug Saf, 2008;31:419–23.
   PubMed Web of Science ®Google Scholar
• Mora-Huertas CE, Fessi H, Elaissari A. Polymer-based nanocapsules for drug delivery. Int J Pharm, 2010;385:113–42.
   PubMed Web of Science ®Google Scholar
• Moses M, Brem H, Langer R. 2003. Novel delivery systems in cancer chemotherapy. Narberth, PA: Science & Medicine, Inc.
   Google Scholar
• Mukerjee A, Vishwanatha JK. Formulation, characterisation, and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res, 2009;29:3867–75.
   PubMed Web of Science ®Google Scholar
• Müller R. 1991. Colloidal carriers for controlled drug delivery and targeting: Modification, characterisation, and in vivo distribution. Boca Raton, FL: CRC Press.
   Google Scholar
• Nagasaka H, Inoue I, Inui A, Komatsu H, Sogo T, Murayama K, Murakami T, Yorifuji T, Asayama K, Katayama S, et al. Relationship between oxidative stress and antioxidant systems in the liver of patients with Wilson disease: Hepatic manifestation in Wilson disease as a consequence of augmented oxidative stress. Pediatr Res, 2006;60:472–7.
   PubMed Web of Science ®Google Scholar
• Nimse SB, Pal D. Free radicals, natural antioxidants, and their reaction mechanisms. RSC Adv, 2015;5:27986–8006.
   Web of Science ®Google Scholar
• Porsolt R, Bertin A, M J. Behavioural despair in mice: A primary screening test for antidepressants. Arch Int Pharmacodyn Ther, 1977;229:327–36.
   PubMedGoogle Scholar
• Qin XY, Cheng Y, Yu LC. Potential protection of curcumin against intracellular amyloid β-induced toxicity in cultured rat prefrontal cortical neurons. Neurosci Lett, 2010;480:21–4.
   PubMed Web of Science ®Google Scholar
• Rajakumar DV, Rao MN. Antioxidant properties of dehydrozingerone and curcumin in rat brain homogenates. Mol Cell Biochem, 1994;140:73–9.
   PubMed Web of Science ®Google Scholar
• Rajeswari A, Sabesan M. Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin, and its metabolite tetrahydrocurcumin, in a model of Parkinson’s disease induced by MPTP neurodegeneration in mice. Inflammopharmacology, 2008;16:96–9.
   PubMedGoogle Scholar
• Reeta KH, Mehla J, Gupta YK. Curcumin ameliorates cognitive dysfunction and oxidative damage in phenobarbitone and carbamazepine administered rats. Eur J Pharmacol, 2010;644:106–12.
   PubMed Web of Science ®Google Scholar
• Ryter SW, Kim HP, Hoetzel A, Park JW, Nakahira K, Wang X, Choi AM. Mechanisms of cell death in oxidative stress. Antioxid Redox Signal, 2007;9:49–89.
   PubMed Web of Science ®Google Scholar
• Sahoo N, Manchikanti P, Dey SH. Herbal drug patenting in India: IP potential. J Ethnopharmacol, 2011;137:289–97.
   PubMed Web of Science ®Google Scholar
• Samojlik I, Mijatovic V, Gavaric N, Krstin S, Bozin B. Consumers' attitude towards the use and safety of herbal medicines and herbal dietary supplements in Serbia. Int J Clin Pharm, 2013;35:835–40.
   PubMed Web of Science ®Google Scholar
• Sarandol A, Sarandol E, Eker SS, Erdinc S, Vatansever E, Kirli S. Major depressive disorder is accompanied with oxidative stress: Short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol, 2007;22:67–73.
   PubMed Web of Science ®Google Scholar
• Sen T, Samanta SK. Medicinal plants, human health, and biodiversity: A broad review. Adv Biochem Eng Biotechnol, 2015;147:59–110.
   PubMed Web of Science ®Google Scholar
• Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MNVR. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci, 2009;37:223–30.
   PubMed Web of Science ®Google Scholar
• Shen L, Ji HF. Theoretical study on physicochemical properties of curcumin. Spectrochim Acta Part A, 2007;67:619–23.
   PubMed Web of Science ®Google Scholar
• Singh R, Navneet C, Singh V. In-silico study of herbal compounds (bacailin, curcumin, and dronabinol) as novel MAO inhibitors for Parkinson’s disease treatment. Int J Life Sci Pharma Res, 2012;2:L81–98.
   Google Scholar
• Steel Z, Marnane C, Iranpour C, Chey T, Jackson JW, Patel V, Silove D. The global prevalence of common mental disorders: A systematic review and meta-analysis 1980–2013. Int J Epidemiol, 2014;43:476–93.
   PubMed Web of Science ®Google Scholar
• Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology (Berl), 1985;85:367–70.
   PubMed Web of Science ®Google Scholar
• Thankamma A, Radhika LG, Soudamini C. Detection and estimation of Curcumba longa in ayurvedic preparations. Anc Sci Life, 1995;15:43–52.
   PubMedGoogle Scholar
• Vauthier C, Dubernet C, Chauvierre C, Brigger I, Couvreur P. Drug delivery to resistant tumours: the potential of poly (alkyl cyanoacrylate) nanoparticles. J Control Release, 2003;93:151–60.
   PubMed Web of Science ®Google Scholar
• Weinreb O, Amit T, Bar-Am O, Youdim MB. Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and beta-amyloid in aging and Alzheimer's disease. Br J Pharmacol, 2016;173:2080–94.
   PubMed Web of Science ®Google Scholar
• Wu HF, Chen K, Shih JC. Site-directed mutagenesis of monoamine oxidase A and B: Role of cysteines. Mol Pharmacol, 1993;43:888–93.
   PubMed Web of Science ®Google Scholar
• Yusuf M, Khan M, Al-Ghamdi SBA, Maghrabi IA. Modified methods of extraction of polyene antioxidants piperine, curcumin and β-carotene. Indian Res J Pharm Sci, 2016;8:471–85.
   Google Scholar
• Yusuf M, Khan M, Khan R, Ahmed B. Preparation, characterisation, in vivo and biochemical evaluation of brain targeted piperine solid lipid nanoparticles in an experimentally induced Alzheimer disease model. J Drug Target, 2013;21:300–11.
   PubMed Web of Science ®Google Scholar
• Yusuf M, Khan RA, Ahmed B. Syntheses and anti-depressant activity of 5-amino-1,3,4-thiadiazole-2-thiol imines and thiobenzyl derivatives. Bioorg Med Chem, 2008;16:8029–34.
   PubMed Web of Science ®Google Scholar
• Yusuf M, Khan RA, Khan M, Ahmed B. Plausible antioxidant biomechanics and anticonvulsant pharmacological activity of brain-targeted β-carotene nanoparticles. Int J Nanomedicine, 2012;7:4311–22.
   PubMed Web of Science ®Google Scholar
• Zhang ZY, Jiang M, Fang J, Yang MF, Zhang S, Yin YX, Li DW, Mao LL, Fu XY, Hou YJ, et al. Enhanced therapeutic potential of nano-curcumin against subarachnoid haemorrhage-induced blood-brain barrier disruption through inhibition of inflammatory response and oxidative stress. Mol Neurobiol, 2015. [Epub ahead of print]. doi: 10.1007/s12035-015-9635-y.
   Google Scholar
• Zolnik BS, Burgess DJ. Effect of acidic pH on PLGA microsphere degradation and release. J Control Release, 2007;122:338–44.
   PubMed Web of Science ®Google Scholar
• Zolnik BS, Leary PE, Burgess DJ. Elevated temperature accelerated release testing of PLGA microspheres. J Control Release, 2006;112:293–300.
   PubMed Web of Science ®Google Scholar